Based on a disruptive technology, the fastest point-of-care sepsis diagnostic platform.

  • Point-of-care diagnostic platform
  • One drop of blood
  • Fluorescently-labeled detecting antibody
  • Nanofluidic immunoassay
  • Time-to-results: 5 minutes
abioScope ®
  • Platform that enables the earliest and point-of-care detection of sepsis in just 5 minutes.

  • abioSCOPE® is able to early identify patients at high risk of sepsis, thanks to the combination of nanofluidic technologies and the detection of a potential sepsis biomarker: the Pancreatic Stone Protein (PSP).
    is an host protein biomarker for identification of patients at risk of infection-related organ dysfunction. It is produced mostly by the acinar cells of the pancreas and its blood level rises in the presence of a remote sepsis-related organ dysfunction.

    PSP allows early identification of sepsis with high sensitivity and specificity.

    The 5 minutes immunoassay test with PSP and abioSCOPE allows to identify sepsis as early as possible, in order to optimize selection and timing of the Antibiotic Treatment.

Do you need more information?

Contact us